coronaviru
diseas
highli
pathogen
viral
infect
caus
current
caus
global
health
concern
assum
zoonot
origin
base
larg
number
infect
peopl
expos
wet
market
wuhan
citi
china
phylogenet
analysi
reveal
signific
sequenc
similar
sever
acut
respiratori
syndromelik
sarslik
bat
virus
thu
bat
could
primari
possibl
reservoir
intermedi
host
subsequ
transfer
known
yet
although
human
human
transfer
wide
confirm
transmiss
infect
one
person
anoth
result
isol
patient
subsequ
given
varieti
treatment
monitor
current
outbreak
robust
step
taken
around
globe
reduc
transmiss
infect
particularli
ban
intern
domest
flight
induct
lockdown
vulner
area
social
distanc
etc
clinic
approv
antivir
drug
vaccin
report
yet
howev
clinic
trial
broadspectrum
antivir
drug
evalu
infect
result
clinic
recoveri
articl
emerg
pathogen
infect
along
potenti
therapeut
strategi
analyz
combat
pandem
coronaviru
one
major
pathogen
target
primarili
human
respiratori
system
earlier
coronavir
outbreak
cov
includ
middl
east
respiratori
syndrom
mer
cov
sever
acut
respiratori
syndrom
sar
cov
significantli
caus
great
threat
human
be
decemb
number
patient
admit
hospit
initi
diagnosi
pneumonia
patient
found
epidemiolog
link
wet
anim
seafood
wholesal
market
wuhan
hubei
provinc
china
earli
studi
predict
onset
possibl
coronaviru
outbreak
februari
estim
reproduct
number
significantli
larg
rang
decemb
first
case
infect
report
decemb
decemb
patient
acut
respiratori
distress
syndrom
hospit
among
one
patient
die
upto
januari
patient
identifi
possess
laboratori
confirm
infect
almost
half
patient
underli
diseas
particularli
cardiovascular
diseas
hypertens
diabet
believ
patient
infect
hospit
possibl
due
nosocomi
infect
thu
conclud
superhot
spread
viru
spread
mani
other
one
patient
like
spread
mani
patient
get
infect
unknown
mechan
differ
locat
hospit
furthermor
patient
test
clinic
sick
probabl
sever
patient
infect
januari
total
infect
case
report
provinc
china
upto
januari
china
nation
health
commiss
report
detail
first
death
januari
total
infect
case
confirm
along
death
mainland
china
anoth
report
januari
estim
infect
china
first
infect
case
report
januari
led
identif
descript
clinic
diagnosi
manag
case
includ
initi
mild
symptom
patient
lead
pneumonia
day
ill
moreov
januari
first
case
humantohuman
transmiss
report
us
http
wwwcdc
april
total
number
covid
fig
infect
symptom
start
appear
incub
period
day
wang
et
al
report
time
period
onset
symptom
death
rang
day
median
time
period
depend
patient
immun
system
age
patient
found
shorter
among
patient
year
age
rel
year
patient
common
symptom
onset
infect
fatigu
cough
fever
symptom
includ
lymphopenia
haemoptysi
headach
sputum
product
diarrhea
chest
ct
scan
reveal
pneumonia
nevertheless
clinic
featur
like
acut
cardiac
injuri
acut
respiratori
distress
syndrom
rnaaemia
incid
grandglass
opac
lead
death
certain
case
sever
peripher
groundglass
opac
identifi
subpleur
region
lung
like
induc
local
system
immun
respons
lead
increas
inflamm
unfortun
interferon
inhal
therapi
show
therapeut
benefit
instead
aggrav
disord
worsen
pulmonari
opac
pertin
mention
symptom
earlier
betacoronaviru
infect
bilater
groundglass
opac
ct
scan
dri
cough
dyspnea
fever
similar
importantli
show
uniqu
clinic
featur
like
target
lower
airway
evid
symptom
like
sore
throat
rhinorrhoea
sneez
addit
basi
chest
radiograph
result
case
found
possess
infiltr
upper
lobe
lung
associ
increas
dyspnea
hypoxemia
although
patient
report
gastrointestin
gi
symptom
like
diarrhoea
small
percentag
sarscov
merscov
patient
experienc
similar
gi
distress
henc
analyz
faecal
urin
sampl
necessari
elimin
possibl
altern
rout
transmiss
specif
health
care
staff
patient
etc
therefor
develop
method
identifi
differ
mode
transmiss
feacal
urin
sampl
urgent
need
establish
strategi
inhibit
andor
reduc
transmiss
develop
therapeut
manag
diseas
first
four
case
acut
respiratori
syndrom
unknown
etiolog
identifi
among
peopl
link
local
seafood
market
wet
market
wuhan
citi
china
decemb
research
progress
learn
transmiss
frequenc
featur
observ
earli
detect
case
kind
histori
interact
seafood
market
eventu
humantohuman
transmiss
close
contact
found
secondari
caus
infect
rise
frequenc
infect
individu
histori
wildlif
exposur
visit
wuhan
sever
case
infect
identifi
among
medic
profession
well
becom
appar
infect
occur
upon
exposur
viru
normal
immunosuppress
popul
seem
suscept
adult
patient
year
age
fewer
case
found
among
children
infant
research
dynam
earli
transmiss
viru
report
median
age
patient
year
rang
year
major
male
peopl
low
immun
function
particularli
old
age
peopl
renal
hepat
dysfunct
consid
high
risk
group
found
higher
rate
transmiss
pandem
risk
sarscov
effect
reproduct
number
r
much
higher
record
effect
reproduct
number
r
sar
differ
studi
estim
basic
reproduct
r
rang
averag
incub
durat
estim
rang
day
chines
health
author
recent
report
averag
incub
day
rang
day
find
epidemiolog
studi
base
import
indic
summar
tabl
coronavirus
singlestrand
zoonot
rna
virus
caus
symptom
rang
common
cold
extrem
respiratori
enter
hepat
neurolog
symptom
besid
six
coronavirus
report
human
sarscov
merscov
last
two
decad
coronaviru
caus
two
major
pandem
sar
mer
order
find
sourc
outbreak
cdc
research
china
collect
environment
sampl
huanan
seafood
market
wuhan
hubei
provinc
found
sampl
suggest
came
wild
anim
sold
market
research
also
use
lung
fluid
blood
throat
swab
sampl
patient
laboratori
elderli
peopl
peopl
poor
immun
function
peopl
chronic
comorbid
surgeri
histori
admiss
research
laboratori
studi
reveal
virusspecif
nucleic
acid
sequenc
sampl
vari
known
human
coronaviru
speci
laboratori
find
also
show
sar
ident
beta
coronavirus
genera
found
bat
locat
sarssarslik
cov
group
conduct
nextgener
sequenc
cultur
isol
bronchoalveolar
lavag
fluid
nine
inpati
enrol
research
wuhan
viral
pneumonia
without
common
respiratori
pathogen
result
indic
distinct
merscov
approxim
sequenc
ident
sarscov
approxim
sequenc
ident
two
batderiv
sarslik
coronavirus
sequenc
ident
sequenc
ident
studi
also
show
sprotein
strongli
interact
human
molecul
spite
dissimilar
sequenc
sarscov
case
fatal
rate
cfr
diseas
fix
vari
locat
time
report
cfr
vari
wide
countri
rang
germani
itali
may
accur
comparison
true
likelihood
particularli
like
sinc
awar
weather
criterion
test
appli
countri
mani
case
symptomat
vs
asymptomat
better
decis
make
understand
differ
cfr
need
better
data
howev
care
acknowledg
limit
cfr
help
us
understand
pandem
better
done
combat
itth
countri
small
number
confirm
case
till
left
cfr
small
sampl
size
signific
look
toward
trajectori
case
iran
februari
confirm
case
death
implaus
cfr
number
case
increas
hundr
time
cfr
drop
level
seen
countri
cfr
ongo
pandem
repres
fig
anticip
probabl
zoonot
origin
base
larg
number
infect
peopl
expos
wet
anim
market
wuhan
citi
live
anim
routin
sold
effort
made
look
host
reservoir
intermedi
carrier
infect
could
spread
human
two
snake
speci
identifi
thought
possibl
reservoir
howev
clear
cut
evid
reservoir
coronaviru
mammal
bird
till
date
genom
sequenc
analysi
show
ident
two
batderiv
sever
acut
respiratori
syndrom
sar
like
coronavirus
suggest
bat
like
link
human
sever
studi
indic
transmiss
person
person
possibl
way
infect
spread
observ
infect
occur
mani
peopl
even
visit
wuhan
wet
anim
market
transmiss
diseas
person
person
occur
mainli
direct
contact
droplet
releas
infect
person
cough
sneez
fig
quickli
diseas
spread
countri
sinc
confirm
case
studi
conduct
infect
women
third
trimest
evid
analyz
confirm
transmiss
occur
mother
child
nevertheless
pregnant
mother
underw
cesarean
section
remain
uncertain
transmiss
occur
vagin
deliveri
studi
import
pregnant
women
compar
vulner
respiratori
infect
extrem
pneumonia
first
step
viral
infect
bind
receptor
express
host
cell
follow
fusion
cell
membran
lung
epitheli
cell
primari
target
viru
state
humantohuman
transmiss
sarscov
occur
bind
cellular
receptor
known
angiotensinconvert
enzym
receptor
receptorbind
domain
viru
spike
import
mention
receptor
bind
domain
sequenc
similar
sarscov
result
indic
like
entri
host
cell
receptor
classifi
cov
group
world
health
organ
genom
sequenc
nine
patient
show
sequenc
ident
anoth
studi
five
patient
show
nucleotid
ident
sequenc
studi
reveal
presenc
new
betacov
strain
genet
sequenc
show
ident
merscov
sarscov
merscov
sarscov
origin
bat
seventh
member
coronaviru
famili
infect
human
categor
subfamili
orthocoronavirina
clade
within
subgenu
sarbecoviru
basi
phylogenet
report
genet
sequenc
studi
vari
significantli
sarscov
thu
regard
new
betacoronaviru
infect
human
like
develop
bat
origin
coronavirus
anoth
evid
support
bat
origin
high
homolog
receptor
divers
anim
speci
implic
anim
speci
possibl
intermedi
host
anim
model
infect
addit
virus
singl
intact
open
read
frame
gene
anoth
sign
batorigin
cov
nevertheless
amino
acid
sequenc
receptorbind
domain
resembl
sarscov
indic
virus
might
use
receptor
complet
clinic
manifest
yet
clear
symptom
record
far
vari
mild
extrem
case
even
lead
death
frequent
report
symptom
includ
coughproduc
phlegm
runni
nose
myalgia
fever
pneumonia
complic
dyspnea
less
wide
document
symptom
includ
headach
vomit
hemoptysi
patient
mild
symptom
usual
recov
within
week
sever
case
report
suffer
progress
respiratori
failur
due
alveolar
damag
lead
death
well
usual
elderli
patient
middl
age
patient
preexist
diseas
coronari
heart
diseas
parkinson
diseas
diabet
hypertens
tumor
surgeri
cirrhosi
seen
prone
death
case
definit
guidelin
mention
follow
symptom
decreas
lymphocyt
white
blood
cell
fever
new
pulmonari
infiltr
chest
radiographi
improv
symptom
day
antibiot
treatment
patient
suspect
infect
follow
techniqu
diagnosi
suggest
conduct
realtim
fluoresc
rtpcr
detect
posit
nucleic
acid
sputum
throat
swab
lower
respiratori
tract
sampl
secret
vaccin
current
avail
neither
specif
antivir
treatment
recommend
far
treatment
symptomat
patient
sever
infect
given
oxygen
therapi
case
respiratori
failur
mechan
ventil
requir
wherea
hemodynam
support
import
septic
shock
manag
januari
releas
document
summar
guidelin
clinic
data
obtain
treatment
previou
hcov
epidem
document
address
step
identif
sort
patient
seriou
acut
respiratori
diseas
guidelin
laboratori
diagnosi
earli
support
therapi
monitor
manag
septic
shock
respiratori
failur
method
treatment
pregnant
patient
amongst
recommend
focu
approach
tackl
respiratori
failur
includ
safe
mechan
ventil
noninvas
ventil
niv
highflow
nasal
oxygen
hfno
intub
special
precaut
requir
profession
oper
use
person
protect
equip
ppe
protect
goggl
dispos
doubl
sock
dispos
glove
ffp
n
mask
dispos
gown
long
sleev
raincoat
conduct
oper
rapid
sequenc
intub
rsi
perform
possibl
preoxygen
perform
minut
use
method
continu
posit
airway
pressur
cpap
heat
moistur
exchang
hme
must
locat
circuit
fan
mask
ventil
balloon
mask
case
mechan
ventil
lower
inspiratori
pressur
reach
plateau
pressur
pplat
cm
h
lower
tidal
volum
mlkg
predict
bodi
weight
pbw
kept
posit
end
expiratori
pressur
peep
kept
high
possibl
maintain
drive
pressur
pplatpeep
low
possibl
cm
h
furthermor
prevent
atelectasi
loss
peep
disconnect
ventil
must
avoid
paralyt
recommend
pao
fio
mm
hg
use
conserv
fluid
manag
strategi
prone
ventil
hour
per
day
patient
suffer
acut
respiratori
distress
syndrom
strongli
recommend
regard
high
flow
nasal
oxygen
hfno
noninvas
ventil
niv
panel
expert
point
approach
perform
system
good
interfac
fit
caus
widespread
dispers
exhal
air
use
consid
low
risk
airborn
transmiss
practic
sens
noninvas
ventil
use
non
sever
form
respiratori
failur
nevertheless
patient
improv
even
worsen
within
limit
period
time
hour
mechan
ventil
must
prefer
first
broadspectrum
antibiot
nebul
antivir
drug
use
reduc
viral
load
remdesivir
shown
promis
viral
impact
remdesivir
alon
combin
chloroquin
significantli
block
replic
patient
found
recov
clinic
sever
antivir
drug
current
evalu
infect
moder
result
exhibit
favipiravir
nitazoxanid
ribavirin
baricitinib
penciclovir
ritonavir
arbidol
test
infect
vitro
clinic
isol
patient
mani
formul
also
test
infect
human
mice
combin
antibiot
antivr
drug
tradit
chines
medicin
convalesc
plasma
therapi
also
test
doctor
shanghai
china
usa
well
blood
plasma
isol
clinic
treat
patient
inject
infect
patient
show
posit
result
rapid
recoveri
current
vaccin
avail
infect
howev
vaccin
strategi
use
develop
vaccin
sarscov
effect
recombin
dna
urbani
strain
sarscov
administ
hamster
mice
lead
product
neutral
antibodi
protect
sarscov
dna
found
inactiv
whole
viru
livevector
strain
sarscov
significantli
reduc
viral
infect
anim
model
numer
sarscov
strain
also
use
develop
inactiv
livevector
vaccin
effect
reduc
viral
load
anim
model
strain
includ
fra
utah
moreov
vaccin
pipelin
chines
centr
diseas
control
prevent
cdc
focus
creat
inactiv
vaccin
virus
sampl
mrna
base
vaccin
prepar
stermirna
therapeut
avail
soon
geovax
bravovax
work
format
modifi
vaccina
ankara
mva
base
vaccin
clover
biopharmaceut
develop
recombin
protein
subunittrim
base
vaccin
although
research
team
around
world
work
explor
key
characterist
pathogenesi
combat
diseas
appropri
attent
drawn
therapeut
option
crossresist
vaccin
instanc
vaccin
diseas
like
measl
rubella
creat
crossresist
concept
cross
resist
base
find
children
found
less
vulner
infect
compar
elder
popul
children
predominantli
vaccin
measl
strategi
prevent
control
report
three
level
nation
level
caserel
popul
level
gener
popul
level
case
nation
level
china
nation
health
commiss
issu
announc
offici
includ
manag
legal
infecti
diseas
class
b
allow
class
infecti
diseas
prevent
control
measur
implement
polici
medic
institut
adopt
observ
protocol
isol
treatment
prevent
control
spread
china
nation
health
commiss
issu
nation
guidelin
prevent
control
infect
januari
medic
institut
prevent
nosocomi
infect
januari
chines
spring
festiv
nation
health
commiss
releas
guidelin
rapid
prevent
control
measur
effect
contain
spread
diseas
major
isol
great
disinfect
program
nationallevel
polici
target
measur
elderli
popul
publish
januari
rural
area
releas
januari
also
releas
sever
public
health
intervent
implement
avoid
delay
transmiss
includ
case
isol
identif
surveil
contact
environment
disinfect
use
person
protect
equip
specif
antivir
therapi
confirm
infect
regard
patient
diagnos
recommend
appropri
symptomat
treatment
support
care
appli
studi
also
report
prevent
psycholog
health
issu
nosocomi
infect
associ
covid
seri
measur
suggest
minim
nosocomi
infect
includ
awar
train
prevent
control
isol
disinfect
protect
differ
level
infect
area
protect
report
case
respect
psycholog
health
suggest
psycholog
intervent
set
medic
staff
suspect
case
confirm
case
sinc
vaccin
prevent
moment
best
prevent
gener
popul
avoid
exposur
viru
airborn
measur
protect
discuss
suggest
protect
infect
prevent
control
measur
minim
risk
exposur
includ
use
face
mask
cover
cough
sneez
tissu
safe
dispos
regular
hand
wash
soap
disinfect
hand
sanit
alcohol
maintain
appropri
distanc
much
possibl
avoid
contact
infect
peopl
refrain
touch
nose
mouth
eye
unwash
hand
also
releas
detail
recommend
use
face
mask
within
popul
home
care
health
care
set
health
care
staff
advis
use
particul
respir
licens
n
ffp
conduct
aerosolgener
procedur
use
surgic
mask
provid
treatment
suspect
confirm
case
per
guidelin
individu
without
respiratori
symptom
public
requir
wear
medic
mask
avoid
increas
risk
transmiss
proper
use
dispos
mask
import
addit
paper
publish
scientif
journal
china
cdc
provid
guidelin
rais
awar
among
gener
public
prevent
control
guidelin
main
messag
includ
caus
choos
wear
face
mask
proper
hand
wash
practic
prevent
measur
differ
locat
eg
home
public
transport
public
space
method
disinfect
home
medic
monitor
addit
scientif
knowledg
treat
outbreak
guidelin
also
recommend
way
reduc
fear
among
gener
popul
anim
model
play
crucial
role
uncov
mechan
viral
pathogen
entranc
transmiss
scheme
therapeut
strategi
previous
variou
anim
model
use
examin
replic
sarscov
show
symptom
sever
infect
case
merscov
pathogenesi
observ
small
anim
seen
case
sarscov
mice
found
suscept
merscoronaviru
infect
noncompat
dpp
receptor
entir
genom
similar
previou
human
sarslik
bat
cov
henc
anim
model
previous
use
sarscov
may
use
studi
pathogen
novel
coronavirus
sar
recogn
human
ace
cell
receptor
conclus
talen
crisprmedi
genet
modifi
hamster
small
anim
may
use
test
pathogen
novel
coronavirus
observ
sarscov
mutat
spike
glycoprotein
replic
caus
sever
diseas
rat
thu
spike
glycoprotein
target
therapeut
suitabl
option
coronavirus
recent
studi
formul
therapeut
strategi
clinic
isol
mice
model
use
artifici
intellig
predict
also
use
similar
studi
investig
inhibitori
role
drug
random
clinic
trial
also
use
patient
essenti
scientist
worldwid
collabor
design
effect
model
investig
vivo
mechan
associ
pathogenesi
combat
current
outbreak
requir
rigor
step
reduc
transmiss
infect
person
person
special
attent
effort
appli
protect
reduc
transmiss
vulner
popul
includ
infant
health
care
provid
elderli
medic
personnel
health
care
profession
public
health
individu
research
involv
guidelin
follow
publish
earli
death
case
outbreak
occur
mainli
elderli
possibl
due
poor
immun
system
allow
rapid
progress
viral
infect
decontamin
regent
provid
public
servic
facil
regularli
physic
contact
contamin
thing
particularli
urin
facec
sampl
consid
deal
viru
potenti
serv
altern
rout
transmiss
countri
around
world
particularli
us
china
india
uae
etc
implement
major
control
prevent
measur
like
implement
state
wise
countri
wise
lockdown
travel
screen
control
viru
spread
epidemiolog
chang
occur
infect
monitor
care
take
account
potenti
transmiss
rout
subclin
infect
well
adapt
evolut
possibl
intermedi
anim
reservoir
spread
viru
among
human
larg
number
issu
still
remain
address
mani
test
percentag
came
posit
weather
rate
remain
constant
vari
proposit
peopl
test
posit
show
clinic
symptom
far
paediatr
case
report
real
lack
suscept
due
inadequ
test
